Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Bagby

Showing results (101-110 of 140) with videos related to

Pageof 14
Sort By:
Journal of Visualized Experiments : Jove|January 2, 2023
Testing Cancer Immunotherapeutics in a Humanized Mouse Model Bearing Human TumorsJordi M Lanis, Matthew S Lewis, Hannah Strassburger, et al.
Endocrine-Related Cancer|July 21, 2019
Targeting PDZ-binding kinase is anti-tumorigenic in novel preclinical models of ACCAdwitiya Kar, Yu Zhang, Betelehem W Yacob, et al.
Journal of Psychosomatic Research|March 19, 2017
An evaluation of the absolute and relative stability of alexithymia over 11years in a Finnish general populationA Hiirola, S Pirkola, M Karukivi, et al.
Molecular Cancer Therapeutics|August 11, 2021
Targeting CDK4/6 Represents a Therapeutic Vulnerability in Acquired BRAF/MEK Inhibitor-Resistant MelanomaKelsey W Nassar, Jennifer D Hintzsche, Stacey M Bagby, et al.
Clinical Cancer Drugs|January 12, 2019
Evaluation of TAK-264, an Antibody-Drug Conjugate in Pancreatic Cancer Cell Lines and Patient-Derived Xenograft ModelsAnna R Schreiber, Anna Nguyen, Stacey M Bagby, et al.
Breast Cancer Research : BCR|March 1, 2024
Overcoming doxorubicin resistance in triple-negative breast cancer using the class I-targeting HDAC inhibitor bocodepsin/OKI-179 to promote apoptosisStephen G Smoots, Anna R Schreiber, Marilyn M Jackson, et al.
Cancers|March 25, 2020
Wee1 Inhibition Enhances the Anti-Tumor Effects of Capecitabine in Preclinical Models of Triple-Negative Breast CancerTodd M Pitts, Dennis M Simmons, Stacey M Bagby, et al.
Nature Computational Science|March 4, 2024
Population-level comparisons of gene regulatory networks modeled on high-throughput single-cell transcriptomics dataDaniel Osorio, Anna Capasso, S Gail Eckhardt, et al.
Anti-Cancer Drugs|July 27, 2018
Dual compartmental targeting of cell cycle and angiogenic kinases in colorectal cancer modelsAnna Capasso, Todd M Pitts, Peter J Klauck, et al.
Molecular Cancer Therapeutics|November 29, 2018
Inhibition of MERTK Promotes Suppression of Tumor Growth in BRAF Mutant and BRAF Wild-Type MelanomaLenka Sinik, Katherine A Minson, John J Tentler, et al.
Pageof 14

Showing results (101-110 of 140) with videos related to

Sort By:
Pageof 14
Journal of Visualized Experiments : Jove|January 2, 2023
Testing Cancer Immunotherapeutics in a Humanized Mouse Model Bearing Human TumorsJordi M Lanis, Matthew S Lewis, Hannah Strassburger, et al.
Endocrine-Related Cancer|July 21, 2019
Targeting PDZ-binding kinase is anti-tumorigenic in novel preclinical models of ACCAdwitiya Kar, Yu Zhang, Betelehem W Yacob, et al.
Journal of Psychosomatic Research|March 19, 2017
An evaluation of the absolute and relative stability of alexithymia over 11years in a Finnish general populationA Hiirola, S Pirkola, M Karukivi, et al.
Molecular Cancer Therapeutics|August 11, 2021
Targeting CDK4/6 Represents a Therapeutic Vulnerability in Acquired BRAF/MEK Inhibitor-Resistant MelanomaKelsey W Nassar, Jennifer D Hintzsche, Stacey M Bagby, et al.
Clinical Cancer Drugs|January 12, 2019
Evaluation of TAK-264, an Antibody-Drug Conjugate in Pancreatic Cancer Cell Lines and Patient-Derived Xenograft ModelsAnna R Schreiber, Anna Nguyen, Stacey M Bagby, et al.
Breast Cancer Research : BCR|March 1, 2024
Overcoming doxorubicin resistance in triple-negative breast cancer using the class I-targeting HDAC inhibitor bocodepsin/OKI-179 to promote apoptosisStephen G Smoots, Anna R Schreiber, Marilyn M Jackson, et al.
Cancers|March 25, 2020
Wee1 Inhibition Enhances the Anti-Tumor Effects of Capecitabine in Preclinical Models of Triple-Negative Breast CancerTodd M Pitts, Dennis M Simmons, Stacey M Bagby, et al.
Nature Computational Science|March 4, 2024
Population-level comparisons of gene regulatory networks modeled on high-throughput single-cell transcriptomics dataDaniel Osorio, Anna Capasso, S Gail Eckhardt, et al.
Anti-Cancer Drugs|July 27, 2018
Dual compartmental targeting of cell cycle and angiogenic kinases in colorectal cancer modelsAnna Capasso, Todd M Pitts, Peter J Klauck, et al.
Molecular Cancer Therapeutics|November 29, 2018
Inhibition of MERTK Promotes Suppression of Tumor Growth in BRAF Mutant and BRAF Wild-Type MelanomaLenka Sinik, Katherine A Minson, John J Tentler, et al.
Pageof 14